SOX2 and breast cancer: The highly conserved residues of the C-terminal region of the HMG box can be exploited for the design of synthetic interfering peptides (iPeps) that may interfere with the function of SOX2 in breast cancer cells by competitively disrupting the cooperative interactions in the SOX2/OCT4/DNA complex.